RAC 2.20% $1.78 race oncology ltd

Ann: December 2022 Preclinical & Clinical Programs Update, page-3

  1. 727 Posts.
    lightbulb Created with Sketch. 127
    Beat me to it i just read that and was about to post it ahhh bugger it that kinda thing can be said twice

    Reporting on this project has been delayed as the mice treated with the optimal
    Zantrene and decitabine dose have controlled the growth of the cancer to such an extent
    that the mice have lived far longer than expected.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.